Beyond the Gut: The Role of Intestinal Microbiota in Systemic Diseases and Emerging Clinical Applications

Resumen

The intestinal microbiota has emerged as a fundamental regulator of human health, influencing physiological processes that extend far beyond the gastrointestinal tract. Growing scientific evidence indicates that alterations in microbial composition and functionality are associated with the development and progression of numerous systemic diseases, including metabolic disorders, cardiovascular disease, autoimmune conditions, inflammatory bowel disease, liver disease, and cancer. This review aimed to analyze current evidence regarding the biological mechanisms that connect intestinal microbiota with systemic pathology and to examine the potential clinical implications of microbiome-based interventions. A structured review of scientific literature published in major international biomedical databases was conducted, focusing on studies evaluating microbiota-host interactions, immune regulation, inflammatory pathways, metabolic homeostasis, and therapeutic applications. The findings demonstrate that immune dysregulation, increased intestinal permeability, chronic low-grade inflammation, and altered microbial metabolite production represent the principal mechanisms linking dysbiosis to systemic disease. Metabolic and inflammatory disorders showed the strongest associations with microbiota alterations, while growing evidence supports the role of the microbiome in cardiovascular disease, autoimmune conditions, liver disease, and oncological outcomes. Additionally, interventions such as probiotics, prebiotics, dietary modulation, synbiotics, postbiotics, and fecal microbiota-based therapies have demonstrated promising therapeutic potential. Evidence from Mexico, Colombia, and Ecuador highlights the importance of geographic and population-specific factors in shaping microbial diversity and disease susceptibility. Although important methodological and translational challenges remain, current knowledge supports the concept that intestinal microbiota represents a critical determinant of systemic health. Continued advances in microbiome research may contribute to the development of personalized preventive and therapeutic strategies across multiple medical specialties.